RCUS compared with ASMB: revenue, margins and what each company keeps, and the suppliers and customers both name

RCUSArcus Biosciences, Inc.

Mkt capRevenueRevenue

ASMBAssembly Biosciences, Inc.

Mkt capRevenueRevenue

Compare

RCUSArcus Biosciences, Inc.

ASMBAssembly Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RCUS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.2%▲+2.27%×0.21

May 6 '26±18.0%▼−0.23%×0.01

Q1 FY26±19.9%▼−3.60%×0.18

Oct 29 '25±17.7%▲+2.06%×0.12

ASMB1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.5%▲+10.02%×1.18

= impliedRCUS realized, solidASMB realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

RCUSArcus Biosciences, Inc.

17.90▼−1.62%

Mkt cap$2.3BRevenue$41MQ2 FY26Revenue$247MFY25

ASMBAssembly Biosciences, Inc.

19.65▼−2.39%

Regular sessionNov 2 '26

Mkt cap$409.9MRevenue$13MQ2 FY26Revenue$72MFY25

Compare

Regular sessionNov 2 '26

RCUSArcus Biosciences, Inc.

ASMBAssembly Biosciences, Inc.

17.90▼−1.62%

Price

19.65▼−2.39%

$2.3B

Mkt cap

$409.9M

Q2 FY26$41M

Revenue

$13MQ2 FY26

FY25$247M

Revenue

$72MFY25

RCUS17.90▼−1.62%vsASMB19.65▼−2.39%Regular sessionNov 2 '26